Showing results (331-340 of 5,582) with videos related to

Sort By:
Pageof 559
Nuclear Medicine Communications|March 14, 2002
Significant reduction of 125 I-meta-iodobenzylguanidine accumulation directly caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine, a toxic agent for inducing experimental Parkinson's diseaseH Takatsu, H Wada, N Maekawa, et al.
Nuclear Medicine Communications|March 14, 2002
99m Tc-ciprofloxacin (Infecton) imaging in the diagnosis of knee prosthesis infectionsM J Larikka, A K Ahonen, O Niemelä, et al.
Nuclear Medicine Communications|March 14, 2002
Estimation of left ventricular systolic pressure by the left ventricular volume-time curve obtained from electrocardiograph gated 99m Tc-tetrofosmin single photon emission tomography using quantitative gated SPECTK Ban, M Nagaoka, T Nakajima, et al.
Nuclear Medicine Communications|March 14, 2002
Bone marrow scintigraphy with 99m Tc labelled monoclonal anti-NCA 90 Fab' fragment: a feasibility study and comparison of bone marrow uptake with 99m Tc labelled monoclonal anti-NCA 95 antigranulocyte antibodyV Ivancevic, D Huic, A Wolter, et al.
Nuclear Medicine Communications|October 1, 1984
Measurement of 24 hour whole body retention of 99Tcm-diphosphonate by a single thyroid probeP Lang, U Büll
Nuclear Medicine Communications|March 1, 1994
201Tl single photon emission tomography in the evaluation of residual and recurrent astrocytomaH M Moustafa, W M Omar, I Ezzat, et al.
Nuclear Medicine Communications|March 1, 1994
Bone mineral density in patients with Parkinson's disease measured by dual photon absorptiometryC H Kao, C C Chen, S J Wang, et al.
Nuclear Medicine Communications|April 1, 1994
Is somatostatin receptor scintigraphy suited to detection of acute infectious disease?W J Oyen, O C Boerman, R A Claessens, et al.
Nuclear Medicine Communications|April 1, 1994
An expert system approach for the objective interpretation of serum tumour marker levelsS Stajić, R Novaković, V Bosnjaković
Nuclear Medicine Communications|June 1, 1994
Combined use of 123I-labelled BCD-F9 and 4C4 monoclonal antibody with dissimilar specificity for breast cancer: implication for the detection limit of immunolymphoscintigraphy in the assessment of axillary lymph node metastasesC Schatten, M Barrada, R Mandeville, et al.
Pageof 559